Decisions about amniocentesis by advanced maternal age patients following maternal serum screening may not always correlate clinically with screening results: Need for improvement in informed consent process

被引:17
作者
Marini, T
Sullivan, J
Naeem, R
机构
[1] Baylor Coll Med, Dept Mol & Human Genet, Kleberg Cytogenet Lab, Houston, TX 77030 USA
[2] Baystate Med Ctr, Genet Lab, Springfield, MA USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 109卷 / 03期
关键词
multiple-marker serum screening; Down syndrome; AMA; informed consent; amniocentesis;
D O I
10.1002/ajmg.10319
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We evaluated the prenatal diagnosis utilization patterns of advanced maternal age (AMA) patients who underwent serum screening to assess how screening results correlated with their decisions regarding amniocentesis. A 6-year review (1994-1999) of laboratory records identified 2,456 AMA patients who underwent multiple-marker serum screening. The relationship between screening results and patients' decisions on whether or not to undergo amniocentesis was assessed. Among the 841 AMA patients with positive screens, more than half (52%) declined amniocentesis. Of the 1,615 patients with negative serum screening results, 208 (13%) opted for amniocentesis. We concluded that decisions by AMA patients regarding amniocentesis may not always correlate clinically with maternal serum screening results. Possible explanations, including how the state of informed consent may or may not contribute to these decisions, are discussed. It is suggested that understanding the reasons for these decisions may identify opportunities for improving service delivery to all pregnant patients considering prenatal testing. Use of a questionnaire is proposed as one mechanism for gaining a clearer understanding of the possible factors contributing to AMA patient decisions. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:171 / 175
页数:5
相关论文
共 25 条
[1]  
*AM COLL OBST GYN, 1994, INT J GYNECOL OBSTET, V47, P186
[2]   Testing an explanatory model of the development of depressive symptoms in young women during a life transition [J].
Beeber, LS .
JOURNAL OF AMERICAN COLLEGE HEALTH, 1999, 47 (05) :227-234
[3]  
Belknap R A, 1999, Issues Ment Health Nurs, V20, P387, DOI 10.1080/016128499248556
[4]   PRENATAL SCREENING FOR TRISOMY-18 IN THE 2ND TRIMESTER [J].
CANICK, JA ;
PALOMAKI, GE ;
OSATHANONDH, R .
PRENATAL DIAGNOSIS, 1990, 10 (08) :546-548
[5]  
COVINGTON SS, 1994, WOMANS WAY 12 STEPS, P193
[6]  
DeMarco R F, 1998, Health Care Women Int, V19, P539
[7]  
Geller G, 1999, CANCER EPIDEM BIOMAR, V8, P377
[8]   SERUM SCREENING FOR DOWNS-SYNDROME - EXPERIENCES OF OBSTETRICIANS IN ENGLAND AND WALES [J].
GREEN, JM .
BRITISH MEDICAL JOURNAL, 1994, 309 (6957) :769-772
[9]   REDUCING THE NEED FOR AMNIOCENTESIS IN WOMEN 35 YEARS OF AGE OR OLDER WITH SERUM MARKERS FOR SCREENING [J].
HADDOW, JE ;
PALOMAKI, GE ;
KNIGHT, GJ ;
CUNNINGHAM, GC ;
LUSTIG, LS ;
BOYD, PA .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (16) :1114-1118
[10]  
Marteau T., 1992, PSYCHOL HEALTH, V6, P13